Cornerstone Capital Management Holdings’s Jazz Pharmaceuticals JAZZ Stock Holding History

Cornerstone Capital Management Holdings’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-16,778	Closed	-$2.37M	–	1415
2016 Q2	$2.37M	Sell	16,778 -15,416	-48%	-$2.27M	0.02%	683
2016 Q1	$4.2M	Buy	32,194 +2,268	+8%	+$282K	0.04%	509
2015 Q4	$4.21M	Buy	29,926 +7,316	+32%	+$1.01M	0.03%	495
2015 Q3	$3M	Buy	22,610 +21,748	+2,523%	+$3.74M	0.03%	578
2015 Q2	$152K	Buy	+862	New	+$155K	﹤0.01%	1241
2014 Q2	–	Sell	-17,339	Closed	-$2.4M	–	1351
2014 Q1	$2.4M	Sell	17,339 -31,476	-64%	-$4.74M	0.03%	622
2013 Q4	$6.18M	Buy	+48,815	New	+$5.05M	0.07%	356
2013 Q3	–	Sell	-8,293	Closed	-$570K	–	1311
2013 Q2	$570K	Buy	+8,293	New	+$507K	0.01%	904

Other funds holding JAZZ

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Cornerstone Capital Management Holdings's JAZZ Position: Q3 2016 in Review

Cornerstone Capital Management Holdings sold out of Jazz Pharmaceuticals (JAZZ) in Q3 2016, closing a stake of 16,778 shares — an estimated $2.37M sold.

Cornerstone Capital Management Holdings first reported a position in JAZZ in Q2 2013 and held it in 8 quarters. The position peaked at $6.18M in Q4 2013. 325 funds tracked by Wall St. Rank hold JAZZ as of Q3 2016.

Cornerstone Capital Management Holdings reported no remaining Jazz Pharmaceuticals position as of Q3 2016 after selling out during the quarter.
Cornerstone Capital Management Holdings sold 16,778 Jazz Pharmaceuticals shares in Q3 2016, an estimated $2.37M.
Cornerstone Capital Management Holdings first reported a position in Jazz Pharmaceuticals in Q2 2013 and held it in 8 quarters.
Cornerstone Capital Management Holdings's Jazz Pharmaceuticals position peaked at $6.18M in Q4 2013.
325 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2016.

Based on Cornerstone Capital Management Holdings's 13F filing for Q3 2016, filed 16 Nov 2016.